Literature DB >> 17306795

Gene expression changes in long term expanded human neural progenitor cells passaged by chopping lead to loss of neurogenic potential in vivo.

Lucy Anderson1, Rowan M Burnstein, Xiaoling He, Richard Luce, Rob Furlong, Tom Foltynie, Peter Sykacek, David K Menon, Maeve A Caldwell.   

Abstract

Numerous cell culture protocols have been described for the proliferation of multipotent human neural progenitor cells (HNPCs). The mitogen combinations used to expand HNPCs vary, and it is not clear to what extent this may affect the subsequent differentiation of these cells. In this study human foetal cortical tissue was cultured in the presence of either EGF, or FGF-2, or a combination of both using a unique chopping method in which cell to cell contact is maintained. The differentiation potential of neurospheres following mitogen withdrawal was assessed at early (8 weeks) and late (20 weeks) times of expansion, both in vitro and in vivo. In addition, changes in gene expression with time were analysed by microarray experiments. Results show that the presence of FGF-2 was highly predictive of neuronal differentiation after short term culture both in vitro and in vivo. In addition, time in culture had a significant effect on transplant size and neural constituents suggesting that cells have a limited life span and restricted lineage potential. Array analysis confirms that following extensive time in culture cells are entering growth arrest with fundamental expression changes in genes associated with cell cycle regulation, apoptosis and immune functions.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17306795     DOI: 10.1016/j.expneurol.2006.12.025

Source DB:  PubMed          Journal:  Exp Neurol        ISSN: 0014-4886            Impact factor:   5.330


  14 in total

1.  Achieving stable human stem cell engraftment and survival in the CNS: is the future of regenerative medicine immunodeficient?

Authors:  Aileen J Anderson; Daniel L Haus; Mitra J Hooshmand; Harvey Perez; Christopher J Sontag; Brian J Cummings
Journal:  Regen Med       Date:  2011-05       Impact factor: 3.806

2.  Multipotent progenitor cells derived from adult peripheral blood of swine have high neurogenic potential in vitro.

Authors:  Nadja Spitzer; Gregory S Sammons; Heather M Butts; Lawrence M Grover; Elmer M Price
Journal:  J Cell Physiol       Date:  2011-12       Impact factor: 6.384

3.  Gene network disruptions and neurogenesis defects in the adult Ts1Cje mouse model of Down syndrome.

Authors:  Chelsee A Hewitt; King-Hwa Ling; Tobias D Merson; Ken M Simpson; Matthew E Ritchie; Sarah L King; Melanie A Pritchard; Gordon K Smyth; Tim Thomas; Hamish S Scott; Anne K Voss
Journal:  PLoS One       Date:  2010-07-16       Impact factor: 3.240

4.  Real time imaging of human progenitor neurogenesis.

Authors:  Thomas M Keenan; Aaron D Nelson; Jeffrey R Grinager; Jarett C Thelen; Clive N Svendsen
Journal:  PLoS One       Date:  2010-10-07       Impact factor: 3.240

5.  A critical period in cortical interneuron neurogenesis in down syndrome revealed by human neural progenitor cells.

Authors:  Anita Bhattacharyya; Erin McMillan; Serene I Chen; Kyle Wallace; Clive N Svendsen
Journal:  Dev Neurosci       Date:  2009-09-09       Impact factor: 2.984

6.  Human pluripotent stem cells: applications and challenges in neurological diseases.

Authors:  Youssef Hibaoui; Anis Feki
Journal:  Front Physiol       Date:  2012-07-20       Impact factor: 4.566

7.  The protective effect of melatonin on neural stem cell against LPS-induced inflammation.

Authors:  Juhyun Song; So Mang Kang; Kyoung Min Lee; Jong Eun Lee
Journal:  Biomed Res Int       Date:  2015-02-01       Impact factor: 3.411

Review 8.  Parkinson Disease-Mediated Gastrointestinal Disorders and Rational for Combinatorial Therapies.

Authors:  Syed A Ali; Ning Yin; Arkam Rehman; Verline Justilien
Journal:  Med Sci (Basel)       Date:  2016-01-20

9.  Feline Neural Progenitor Cells I: Long-Term Expansion under Defined Culture Conditions.

Authors:  Jing Yang; Jinmei Wang; Ping Gu; X Joann You; Henry Klassen
Journal:  Stem Cells Int       Date:  2012-04-23       Impact factor: 5.443

Review 10.  Stem cell transplantation therapy in Parkinson's disease.

Authors:  Mu-Hui Fu; Chia-Ling Li; Hsiu-Lien Lin; Pei-Chun Chen; Marcus J Calkins; Yu-Fan Chang; Pei-Hsun Cheng; Shang-Hsun Yang
Journal:  Springerplus       Date:  2015-10-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.